Phase III analysis of Emisphere’s oral calcitonin revealed its safty but no reason to continue

Posted by admin on July 23rd, 2010 01:28 PM | No Comment
Phase III analysis of Emisphere’s oral calcitonin revealed its safty but no reason to continue
An independent data monitoring committee (DMC) has weighed in on Novartis and Nordic Biosciences' Phase III study of oral calcitonin for the treatment of osteoarthritis of the knee. After analyzing a year's worth of data from the two-year stu...

J&J unveils phase III results of AIDS drug

Posted by Drug Discovery on July 22nd, 2010 02:58 PM | No Comment
J&J unveils phase III results of AIDS drug
Johnson & Johnson (NYSE: JNJ) unit Tibotec Pharmaceuticals has reported results from two pivotal Phase III trials comparing its investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine) with efavirenz. ...

Onyx Initiates a Phase III Carfilzomib Combination Trial

Posted by admin on July 22nd, 2010 10:39 AM | No Comment
Onyx Initiates a Phase III Carfilzomib Combination Trial
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the company has begun enrollment in the ASPIRE trial, a Phase 3 international clinical trial evaluating carfilzomib in combination with lenalidomide (Revlimid®) and low dose dexamethasone in patients with relapsed multiple myeloma. ...

Avastin-containing regimen showed positive result in Second phase III study

Posted by admin on July 3rd, 2010 12:48 AM | No Comment
Avastin-containing regimen showed positive result in Second phase III study
Second phase III study showed Avastin-containing regimen helped women with ovarian cancer live longer without their disease getting worse Study of Avastin in combination with standard chemotherapy, followed by continued use of Avastin,met primary endpoint of improving progression-free survival in women with ovarian cancer

Vical’s Allovectin-7 Phase III Trial Receives Positive Review

Posted by admin on June 17th, 2010 11:16 AM | No Comment
Vical’s Allovectin-7 Phase III Trial Receives Positive Review
Vical Incorporated (Nasdaq:VICL) today announced that an independent Safety Monitoring Board (SMB) for the company's Phase 3 trial of Allovectin-7® in patients with metastatic melanoma has completed the trial's fourth scheduled safety analysis and recommended that the trial continue per ...

Biogen Idec Announces Enrollment of First Patient in Phase II BG-12 Combination Trial in Multiple Sclerosis

Posted by admin on June 16th, 2010 08:53 AM | No Comment
Biogen Idec Announces Enrollment of First Patient in Phase II BG-12 Combination Trial in Multiple Sclerosis
EXPLORE Trial to Evaluate Oral BG-12 as Combination Therapy for Patients Who Continue to Experience Disease Progression Despite Ongoing Treatment

Denosumab from Amgen shows promise in cancer patients

Posted by admin on June 8th, 2010 09:03 AM | No Comment
Denosumab from Amgen shows promise in cancer patients
US biotechnology major Amgen received a further boost over the weekend, when it announced positive results at the prestigious annual meeting of the American Society of Clinical Oncology (ASCO) being held in Chicago relating to its Prolia (denosumab) which less ...

GSK collaborates on immune disease research

Posted by Drug Discovery on June 4th, 2008 10:59 AM | Comments Off
GSK collaborates on immune disease research
GlaxoSmithKline has inked a five year, $25 million collaboration deal with the Disease Institute of Boston to conduct on immunoinflammation research. GSK and IDI researchers will develop joint grant proposals in targeted areas of research under an All...
Page 4 of 4:« First « 1 2 3 4